Zhiqiang An

USPTO Granted Patents = 39 (Patent Applications = 23)

CIPO Patents = 3 (Patent Applications = 10)

EPO Patents = 7 (Patent Applications = 22)

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 60(Granted Patents)

Location History:

Ambler, PA (US) (2010 - 2018)
Pearland, TX (US) (2017 - 2022)
Houston, TX (US) (2017 - 2024)
Dallas, TX (US) (2023 - 2024)

Company Filing History:

23 out of 5,444

University of Texas System

patents

8 out of 2,405

Merck Sharp + Dohme Corp.

Northwestern University

Immune-onc Therapeutics, Inc.

patent

7. 1 out of 1,579

Washington University

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12331130 - DDR1 antibodies and uses thereof (2025-06-17),

2. 12331110 - Monoclonal antibodies against endotrophin and the use thereof (2025-06-17),

3. 12202895 - LILRB4 antibodies and uses thereof (2025-01-21),

4. 12152071 - EGFL6 specific monoclonal antibodies and methods of their use (2024-11-26),

5. 12084403 - Linkers for antibody drug conjugates (2024-09-10),

6. 12037390 - Leptin antibodies and method of reducing leptin (2024-07-16),

7. 11912758 - Methods of treating metastasis, including inhibiting bone cancer metastasis, by administering an antibody which binds connexin 43 (Cx43) hemichannel (2024-02-27),

8. 11906519 - Methods for identifying LILRB-blocking antibodies (2024-02-20),

9. 11760799 - Leptin antibodies (2023-09-19),

10. 11629122 - Linkers for antibody drug conjugates (2023-04-18),

11. 11498963 - Anti-LILRB antibodies and their use in detecting and treating cancer (2022-11-15),

12. 11377491 - Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer (2022-07-05),

13. 11230591 - CMV neutralizing antigen binding proteins (2022-01-25),

14. 11174320 - HER3 specific monoclonal antibodies for diagnostic and therapeutic use (2021-11-16),

15. 10975142 - Endotrophin neutralization and use thereof (2021-04-13),

Title: Zhiqiang An: Pioneering Inventor from Ambler, PA

Introduction: Zhiqiang An is a distinguished inventor hailing from Ambler, Pennsylvania. His innovative spirit and dedication to technological advancements have made him a prominent figure in the world of patents and inventions.

Latest Patents: Zhiqiang An holds several groundbreaking patents in the fields of renewable energy, sustainable materials, and advanced electronics. His recent patents showcase his commitment to creating solutions for a more sustainable future.

Career Highlights: With a career spanning over two decades, Zhiqiang An has worked with leading research institutions and technology companies to bring his inventions to life. His contributions have significantly impacted various industries, from clean energy to consumer electronics.

Collaborations: Throughout his career, Zhiqiang An has collaborated with top engineers, scientists, and designers to push the boundaries of innovation. His ability to work in multidisciplinary teams has led to the development of cutting-edge technologies with real-world applications.

Conclusion: Zhiqiang An's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His work continues to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.